ENBI — Entheon Biomedical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Entheon Biomedical, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.

	2021 November 30th	2022 November 30th	2023 November 30th	2024 November 30th	2025 November 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2.05	0.68	0.345	0.136	0.322
Net Total Receivables	0.028	0.042	0.006	0.004	0.009
Total Inventory
Prepaid Expenses
Total Current Assets	3.21	0.744	0.396	0.18	0.349
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.164	0	—	—	—
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	9.98	0.769	0.401	0.185	0.354
Payable / Accrued
Notes Payable / Short Term Debt
Total Current Liabilities	0.928	0.155	0.085	0.04	0.03
Total Long Term Debt
Total Debt
Total Liabilities	0.928	0.155	0.085	0.04	0.03
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	9.05	0.615	0.316	0.145	0.324
Total Liabilities & Shareholders' Equity	9.98	0.769	0.401	0.185	0.354
Total Common Shares Outstanding